UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current practice of chronic hepatitis B treatment in Southern Italy

European journal of internal medicine, 2012-07, Vol.23 (5), p.e124-e127

2012

Volltextzugriff (PDF)

C4BQ0: a genetic marker of familial HCV-related liver cirrhosis

Digestive and liver disease, 2004-07, Vol.36 (7), p.471-477

2004

Volltextzugriff (PDF)

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Journal of viral hepatitis, 2015-05, Vol.22 (5), p.469-480

2015

Volltextzugriff (PDF)

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

Digestive and liver disease, 2016-06, Vol.48 (6), p.650-655

2016

Volltextzugriff (PDF)

Sustained response after lamivudine treatment in HBe minus chronic hepatitis B

Journal of hepatology, 2004-05, Vol.40 (5), p.870-871

2004

Volltextzugriff (PDF)

Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial

Italian heart journal, 2000-07, Vol.1 (7), p.475

2000

Volltextzugriff (PDF)

NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients

Nephrology, dialysis, transplantation, 2010-02, Vol.25 (2), p.551-557

2010

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Lancet neurology, 2023-03, Vol.22 (3), p.209-217

2023

Volltextzugriff (PDF)

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial

Headache, 2022-10, Vol.62 (9), p.1153-1163

2022

Volltextzugriff (PDF)

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Cephalalgia, 2024-08, Vol.44 (8), p.3331024241259456

2024

Volltextzugriff (PDF)

Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects

Clinical and translational science, 2024-10, Vol.17 (10), p.e70015-n/a

2024

Volltextzugriff (PDF)

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

PloS one, 2017-10, Vol.12 (10), p.e0185728-e0185728

2017

Volltextzugriff (PDF)

Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders

The American journal of psychiatry, 1996-10, Vol.153 (10), p.1293-1300

1996

Volltextzugriff (PDF)

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment

Clinical and translational science, 2024-07, Vol.17 (7), p.e13813-n/a

2024

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT

Clinical journal of the American Society of Nephrology, 2016-08, Vol.11 (8), p.1377-1383

2016

Volltextzugriff (PDF)

Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

CPT: pharmacometrics and systems pharmacology, 2024-06, Vol.13 (6), p.1044-1054

2024

Volltextzugriff (PDF)

Psychopathological features in referred adolescents with psychogenic nonepileptic seizures with or without epilepsy

Epilepsy & behavior, 2020-11, Vol.112, p.107431-107431, Article 107431

2020

Volltextzugriff (PDF)

Occult hepatitis B and infliximab‐induced HBV reactivation

Inflammatory bowel diseases, 2007-04, Vol.13 (4), p.508-509

2007

Volltextzugriff (PDF)

Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction

The European journal of contraception & reproductive health care, 2024-08, Vol.29 (4), p.171-176

2024

Volltextzugriff (PDF)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center

Kidney international, 2008-04, Vol.73 (S108), p.S76-S80

2008

Volltextzugriff (PDF)

Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double‐blinded, randomized study

Andrology (Oxford), 2017-07, Vol.5 (4), p.771-775

2017

Volltextzugriff (PDF)

Clinical presentations of major depression by African Americans and whites in primary medical care practice

Journal of affective disorders, 1996-12, Vol.41 (3), p.181-191

1996

Volltextzugriff (PDF)

Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study

Andrologia, 2014-10, Vol.46 (8), p.936-942

2014

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(60)
magazinearticle
(2)

Sprache

Englisch
(58)
Italienisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(62)
Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Male
(48)
Female
(43)
Middle Aged
(41)
Aged
(27)
Treatment Outcome
(17)
Adolescent
(15)
Young Adult
(15)
Aged, 80 And Over
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prospective Studies
(10)
Urology & Nephrology
(10)
Italy
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Retrospective Studies
(8)
Antiviral Agents - Therapeutic Use
(7)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current practice of chronic hepatitis B treatment in Southern Italy

C4BQ0: a genetic marker of familial HCV-related liver cirrhosis

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

Air pollution and mortality in twenty-five Italian cities: results of the EpiAir2 Project

Air pollution and urgent hospital admissions in 25 Italian cities: results from the EpiAir2 project

Sustained response after lamivudine treatment in HBe minus chronic hepatitis B

Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial

NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment

Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT

Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

Psychopathological features in referred adolescents with psychogenic nonepileptic seizures with or without epilepsy

Occult hepatitis B and infliximab‐induced HBV reactivation

Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center

Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double‐blinded, randomized study

Clinical presentations of major depression by African Americans and whites in primary medical care practice

Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study

Aktive Filter

Suchergebnisse filtern